2009-11-24 15:08:07 -

Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief executive officer, Carl A. Pelzel will be presenting at Piper Jaffray’s 21 st Annual Health Care Conference in New York City, NY on December 1, 2009 at 4:00 pm EST.

The company will be audio webcasting its presentation and interested parties can access the live or archived presentation for up to 90 days on the company’s website at www.depomed.com : .



About Depomed

Depomed, Inc. is a specialty pharmaceutical company with one product candidate through Phase 3 clinical development, another in Phase 3 clinical development, two approved products on the market and other product candidates in its early stage pipeline. Product candidate DM-1796 has completed Phase 3 clinical development and has been

licensed to Solvay Pharmaceuticals. A New Drug Applications for DM-1796 is expected to be filed with the FDA in the first quarter of 2010. Product candidate Serada TM is in Phase 3 clinical development for menopausal hot flashes. GLUMETZA (R) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and promoted by Santarus, Inc. in the United States. Depomed formulates its products and product candidates with its proven, proprietary Acuform (R) drug delivery technology, which is designed to improve existing oral medications, allowing for extended, controlled release of medications to the upper gastrointestinal tract.
Benefits of Acuform-enhanced pharmaceuticals include the convenience of once-daily administration, improved treatment tolerability and enhanced compliance and efficacy. Additional information about Depomed may be found on its website, www.depomed.com : .


About Piper Jaffray

Piper Jaffray Companies (NYSE: PJC) is a leading, international middle market investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, nonprofit clients and institutional investors. Founded in 1895, Piper Jaffray provides a comprehensive set of products and services, including equity and debt capital markets products; public finance services; mergers and acquisitions advisory services; high-yield and structured products; institutional equity and fixed-income sales and trading; and equity and high-yield research. Piper Jaffray headquarters are located in Minneapolis, Minnesota, with offices across the U.S. and in London, Hong Kong and Shanghai. Piper Jaffray & Co. is the firm's principal operating subsidiary.( www.piperjaffray.com : ) Since 1895. Member SIPC and FINRA.



Depomed, Inc.Sheilah Serradell, 650-462-5900 sserradell@depomed.com : mailto:sserradell@depomed.com